|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 1.730 SEK | -2.81% |
|
0.00% | -8.95% |
| 09-02 | Enzymatica CEO buys additional shares | FW |
| 09-01 | Enzymatica CEO buys 33 384 shares | FW |
Company Valuation: Enzymatica AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 2,671 | 1,305 | 739.2 | 648 | 340.9 | 461.2 |
| Change | - | -51.13% | -43.36% | -12.33% | -47.39% | 35.28% |
| Enterprise Value (EV) 1 | 2,662 | 1,276 | 710.8 | 657.7 | 267.9 | 429.1 |
| Change | - | -52.06% | -44.3% | -7.47% | -59.27% | 60.16% |
| P/E | -202x | -28.2x | -10.1x | -13x | -5.73x | -8.89x |
| PBR | 25x | 10.4x | 5.85x | 8.46x | 2.17x | 3.71x |
| PEG | - | -0x | -0.2x | 0.4x | 0.65x | 0.4x |
| Capitalization / Revenue | 24x | 22.8x | 15.1x | 12.7x | 7.48x | 8.56x |
| EV / Revenue | 23.9x | 22.3x | 14.5x | 12.9x | 5.88x | 7.96x |
| EV / EBITDA | -292x | -29.6x | -10.9x | -14.6x | -5.44x | -8.79x |
| EV / EBIT | -221x | -28.2x | -10.4x | -13.7x | -5.15x | -8.35x |
| EV / FCF | -302x | -50.8x | -16.2x | -40.1x | -5.45x | -19.5x |
| FCF Yield | -0.33% | -1.97% | -6.17% | -2.49% | -18.3% | -5.12% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0926 | -0.3096 | -0.445 | -0.3027 | -0.2759 | -0.2138 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 111.2 | 57.24 | 48.95 | 50.9 | 45.58 | 53.9 |
| EBITDA 1 | -9.122 | -43.1 | -65.08 | -44.96 | -49.22 | -48.83 |
| EBIT 1 | -12.06 | -45.25 | -68.22 | -48.06 | -52.05 | -51.37 |
| Net income 1 | -13.22 | -45.39 | -68.66 | -49.73 | -53.18 | -51.89 |
| Net Debt 1 | -9.165 | -28.98 | -28.37 | 9.712 | -73.01 | -32.11 |
| Reference price 2 | 18.700 | 8.740 | 4.500 | 3.945 | 1.580 | 1.900 |
| Nbr of stocks (in thousands) | 142,824 | 149,324 | 164,257 | 164,257 | 215,769 | 242,735 |
| Announcement Date | 3/31/21 | 3/31/22 | 4/5/23 | 4/9/24 | 4/10/25 | 4/14/26 |
1SEK in Million2SEK
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 43.02M | |
| 32.46x | 11.79x | 23.8x | 0.61% | 1,019B | |
| 28.13x | 6.24x | 17.86x | 2.11% | 610B | |
| 33.64x | 7.86x | 16.24x | 2.61% | 470B | |
| 101.52x | 5.7x | 24.22x | 2.45% | 344B | |
| 18.95x | 4.61x | 11.45x | 2.87% | 336B | |
| 19.74x | 5.16x | 12.75x | 3.1% | 266B | |
| 19.84x | 4.13x | 11.77x | 2.15% | 241B | |
| 25.45x | 6.66x | 11.86x | 2.5% | 218B | |
| -43.74x | 6.39x | 24.95x | 2.28% | 179B | |
| Average | 26.22x | 6.50x | 17.21x | 2.3% | 368.29B | |
| Weighted average by Cap. | 31.25x | 7.60x | 18.53x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ENZY Stock
- Valuation Enzymatica AB
Select your edition
All financial news and data tailored to specific country editions
